Global Search

Hide Filters

Showing 110 results

Media Release / Nov 25, 2025

Novartis Canada Welcomes Dimitri Gitas as New Country President

MONTREAL, QC, November 25, 2025 – Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is pleased to announce the appointment of Dimitri Gitas as Country…
Media Contacts
Health Equity Initiative
Code of Ethics
Diversity, Equity and Inclusion
Media Release / Aug 21, 2025

Leqvio® advances toward broader access with agreement between Novartis and the pan-Canadian Pharmaceutical Alliance

Eligible Canadian patients with heterozygous familial hypercholesterolemia (HeFH) are one step closer to publicly funded access to cholesterol lowering treatment.Montréal, Québec, August 21, 2025 –…
Diseases
Therapeutic Areas
Media Release / Jul 29, 2025

Health Canada expands approval of Scemblix®, making it an option for newly diagnosed and previously treated chronic myeloid leukemia (CML) patients

• Scemblix® is first to show superior efficacy and a favourable safety and tolerability profile in a Phase III trial vs. all standard of care (SoC) therapies.1,2• …
Media Release / Jul 23, 2025

Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS)

• Important milestone towards public reimbursement for a new treatment option for eligible Canadian patients living with moderate to severe hidradenitis suppurativa (HS)• …